Xconomy National

Archives

by in

Entry	Author	Date	Location
Infinity, Idera, Civitas, & More Boston-Area Life Sciences Headlines	Erin Kutz	12/02/11	Boston
Idera Regains Cancer Drug Rights From Germany’s Merck; Stock Climbs	Luke Timmerman	11/30/11	Boston
Amag Eyes Rebound, Idera Surges On Despite Merck KGaA Drop, Verastem Snags $32M, & More Boston-Area Life Sciences News	Erin Kutz	07/15/11	Boston
Former Idera Pharma CEO at Helm of AesRx, New Startup With Sickle Cell Drug	Ryan McBride	01/05/10	Boston
Forma Gets a $25.5M Fix, Novartis Bids Idera Adieu, Alnylam CEO Talks Strategy, & More Boston-Area Life Sciences News	Rebecca Zacks	12/02/09	Boston
Novartis Parts Ways with Idera Pharma	Ryan McBride	11/25/09	Boston
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten	Luke Timmerman	10/08/09	Boston
VentiRx, Evangelist for Lean, Mean Virtual Way, Makes Progress With Cancer, Allergy Drugs	Luke Timmerman	09/17/09	Seattle
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter	Luke Timmerman	03/17/09	Boston
Massachusetts’ Life Sciences Czar Talks Strategy Amid Squeeze on State Spending and Stingy Financial Market	Ryan McBride	01/13/09	Boston
Boston Biotechs Seek Scarce Funds Amid Market Famine at Annual Pitch Event	Ryan McBride	12/04/08	Boston
Resolvyx Closes in on Clinical Trials, Radius Health Reels in $15M, Luke Zeros in on Public Biotechs’ Bottom Line, & More Boston-Area Life Sciences News	Rebecca Zacks	11/26/08	Boston
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter	Luke Timmerman	11/25/08	Boston
SunEthanol Picks Up $25M, New Name; Infinity Pharma Pairs with Purdue Pharma; In-Q-Tel Taps Two Local Firms, & More Boston-Area Deals News	Rebecca Zacks	11/24/08	Boston
Idera and Merck Extend R&D Deal	Ryan McBride	11/20/08	Boston
No Appeal for Boston Scientific, No Luck for CombinatoRx Drug, No Complaints From Harvard, & More Boston-Area Life Sciences News	Rebecca Zacks	10/08/08	Boston
Idera Drug Falls Short in Phase 2	Ryan McBride	10/01/08	Boston
Idera Receives Milestone Payment from Novartis For Asthma and Allergy Collaboration	Luke Timmerman	09/02/08	Boston
Glasshouse Plots for VMware IPO Sequel, Idera Partners With Merck, iRobot Inks Deal With Army, & More	Rebecca Zacks	12/24/07	Boston
Idera Pharmaceuticals Inks Potential $400 Million-Plus Deal with Germany’s Merck	Malorye Allison	12/20/07	Boston
RNAi Firms Find a New Rival (and Partner) in an Old Technology	Malorye Allison	10/04/07	Boston
Page 1 of 1